These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8277796)

  • 41. Prevalence of anti-hepatitis C virus seroconversion in polytransfused thalassemic patients.
    Borzini P; Cazzaniga G; Vecchi L
    Vox Sang; 1991; 60(3):188. PubMed ID: 1650514
    [No Abstract]   [Full Text] [Related]  

  • 42. Low prevalence of antibody to hepatitis C virus in north east England.
    Brind AM; Codd AA; Cohen BJ; Gabriel FG; Collins JD; James OF; Bassendine MF
    J Med Virol; 1990 Dec; 32(4):243-8. PubMed ID: 1964476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hepatitis C virus and renal transplant].
    Ibarra H; Mezzano S; Riegemann S; Toledo C; Ardiles L; Reinhardt G; Castillo A
    Rev Med Chil; 1992 Jan; 120(1):81-2. PubMed ID: 1284811
    [No Abstract]   [Full Text] [Related]  

  • 44. The prevalence of antibody to hepatitis C virus in a dialysis population.
    Hay NM; Lynn KL; Schousboe MI
    N Z Med J; 1992 Apr; 105(931):134. PubMed ID: 1373230
    [No Abstract]   [Full Text] [Related]  

  • 45. Prevalence of anti-HCV antibody in blood donors in the Tokyo area.
    Watanabe J; Minegishi K; Mitsumori T; Ishifuji M; Oguchi T; Ueda M; Tokunaga E; Tanaka E; Kiyosawa K; Furuta S
    Vox Sang; 1990; 59(2):86-8. PubMed ID: 2173281
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical significance and the problems of HCV antibody].
    Yano M
    Nihon Rinsho; 1991 Feb; 49(2):402-8. PubMed ID: 1849200
    [No Abstract]   [Full Text] [Related]  

  • 47. Prevalence of antibody to hepatitis C in patients with liver disease.
    Chia SC; Fock KM; Oon CJ; Chua KL
    Ann Acad Med Singap; 1991 Nov; 20(6):728-31. PubMed ID: 1666491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of hepatitis and seroconversion to hepatitis C virus after open-heart surgery in transfused and non-transfused patients in Sweden.
    Mattsson L; Aberg B; von Sydow M; Weiland O
    Scand J Infect Dis; 1991; 23(1):25-9. PubMed ID: 1851323
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody to hepatitis C virus in 1,305 Italian multiply transfused thalassaemics: a comparison of first and second generation tests. Cooleycare Group.
    Rebulla P; Mozzi F; Contino G; Locatelli E; Sirchia G
    Transfus Med; 1992 Mar; 2(1):69-70. PubMed ID: 1284983
    [No Abstract]   [Full Text] [Related]  

  • 50. [Anti-HCV antibodies and post-transfusional non-A, non-B hepatitis].
    Smilovici W; Trepo C; Marinière AM; Ducos J
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):359-60. PubMed ID: 2177599
    [No Abstract]   [Full Text] [Related]  

  • 51. Antibody to hepatitis-C virus in multitransfused thalassaemics--Indian experience.
    Bhattacharya DK
    J Assoc Physicians India; 1994 Feb; 42(2):174. PubMed ID: 7532165
    [No Abstract]   [Full Text] [Related]  

  • 52. Neopterin as a marker of C hepatitis in thalassaemia major.
    Leonardi S; Avola E; Sciacca A; Di Gregorio F; Musumeci S
    J Pediatr Gastroenterol Nutr; 1991 Apr; 12(3):315-8. PubMed ID: 1649287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HLA-E*01:01 allele is associated with better response to anti-HCV therapy while homozygous status for HLA-E*01:03 allele increases the resistance to anti-HCV treatments in frequently transfused thalassemia patients.
    Hosseini E; Sarraf Kazerooni E; Azarkeivan A; Sharifi Z; Shahabi M; Ghasemzadeh M
    Hum Immunol; 2022 Jul; 83(7):556-563. PubMed ID: 35570067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is anti-HCV blood donor screening useful?
    Fiedler H
    Lancet; 1990 Nov; 336(8724):1193. PubMed ID: 1978051
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of infectious disease markers in multitransfused Egyptian children with thalassemia.
    Hussein E
    Ann Clin Lab Sci; 2014; 44(1):62-6. PubMed ID: 24695476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Second-generation anti-HCV tests and surrogate markers in volunteer blood donors.
    Des Roziers NB; Nasr O
    Transfusion; 1992 Jun; 32(5):492. PubMed ID: 1320782
    [No Abstract]   [Full Text] [Related]  

  • 57. Prevalence of hepatitis C virus antibodies in orthotopic liver transplantation: a sequential study of 72 patients.
    Franza A; Miguet JP; Bresson-Hadni S; Coaquette A; Lab M; Njoya O; Vanhems P; Becker MC; Rouget C; Mantion G
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1506. PubMed ID: 1846472
    [No Abstract]   [Full Text] [Related]  

  • 58. [Infection route of non-transfused type C hepatitis].
    Tanaka E; Furuta S
    Nihon Rinsho; 1991 Feb; 49(2):351-6. PubMed ID: 1849193
    [No Abstract]   [Full Text] [Related]  

  • 59. A prospective study for prevalence and/or development of transfusion-transmitted infections in multiply transfused thalassemia major patients.
    Jain R; Perkins J; Johnson ST; Desai P; Khatri A; Chudgar U; Choudhury N
    Asian J Transfus Sci; 2012 Jul; 6(2):151-4. PubMed ID: 22988380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis C Viral Infection Among Beta-Thalassemia Patients: A Study From the Centre for Excellence in Thalassemia and Other Blood Disorders.
    Kandi V; Vinjamuri SR; Tanikella BP
    Cureus; 2021 Jul; 13(7):e16207. PubMed ID: 34367809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.